Cargando…
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma
INTRODUCTION: Circulating inflammatory cytokines play critical roles in tumor-associated inflammation and immune responses. Recent data have suggested that several interleukins (ILs) mediate carcinogenesis in hepatocellular carcinoma (HCC). However, the predictive and prognostic value of circulating...
Autores principales: | Chamseddine, Shadi, Mohamed, Yehia I., Lee, Sunyoung S., Yao, James C., Hu, Zishuo Ian, Tran Cao, Hop S., Xiao, Lianchun, Sun, Ryan, Morris, Jeffrey S., Hatia, Rikita I., Hassan, Manal, Duda, Dan G., Diab, Maria, Mohamed, Amr, Nassar, Ahmed, Datar, Saumil, Amin, Hesham M., Kaseb, Ahmed Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614568/ https://www.ncbi.nlm.nih.gov/pubmed/37467732 http://dx.doi.org/10.1159/000531870 |
Ejemplares similares
-
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2023) -
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients
por: Mohamed, Yehia I., et al.
Publicado: (2022) -
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
por: Mohamed, Yehia I., et al.
Publicado: (2021) -
Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study
por: Lacin, Sahin, et al.
Publicado: (2020) -
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells
por: Gu, Li, et al.
Publicado: (2023)